Life Science Industry Updates


  • All
  • Manufacturing
  • Marketing
  • Biotech
  • All

    FDA Action Alert: Blueprint, Liquidia, Revance, Rhythm and Merck

    FDA Action Alert: Blueprint, Liquidia, Revance, Rhythm and Merck

    All the latest. Biospace

    Giving the Gift of Time, FDA Approves First Treatment for Rare Childhood Aging Diseases

    You’ll want to read this between meetings. Biospace

    Clinical Catch-Up: November 16-20

    Stay connected to what’s happening in Life Sciences. Biospace

    AstraZeneca, Oxford vaccine prevents COVID-19, though study results raise questions

    Life Science news you need to know. BioPharma Dive

    Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use

    So relevant. BioPharma Dive

    Genscript, Legend Biotech founder arrested in China for suspected smuggling

    Share with a colleague. Fierce Pharma

    AHA: Amarin's Vascepa cuts cardiovascular events in patients with coronary artery grafts

    Let us know what you think about this. Fierce Pharma

    Black Diamond's EFGR-targeted glioblastoma drug candidate slows tumor growth in mice

    Have you read this yet? Fierce Biotech

    Sponsored Ad

    Featured

    AstraZeneca’s COVID-19 Vaccine Boasts Strong Results with Up to 90% Efficacy

    AstraZeneca’s COVID-19 Vaccine Boasts Strong Results with Up to 90% Efficacy

    Expert thoughts. Biospace

    Immunocore's Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

    Passing this around on e-mail today. Biospace

    Merck Bolsters COVID-19 Pipeline with OncoImmune Acquisition

    Share with your team. Biospace

    Sponsored Ad

    Merck, expanding coronavirus work, buys a small biotech and its COVID-19 drug

    What do you think? BioPharma Dive

    Amgen cuts Cytokinetics loose after heart drug disappointment

    Worth the read. BioPharma Dive

    AstraZeneca hopes warmer storage needs for COVID-19 vaccine will be an advantage against mRNA competitors

    You heard it from SOURCE EXPLORER. Fierce Pharma

    Sanofi's hopes for rare blood disease candidate sutimlimab on hold after FDA blasts 3rd-party manufacturer

    Explore recent news. Fierce Pharma

    Merck inks $425M OncoImmune buyout to bag COVID-19 drug

    Straight from the SOURCE. Fierce Biotech

    SOURCE EXPLORER Updates

    How Has COVID Impacted Gender Equality?

    How Has COVID Impacted Gender Equality?

    Sponsored Ad

    Why Less is More — Nootropics and Microdosing

    Why Less is More — Nootropics and Microdosing

    OK, We’ve Just Realized That WFH Has Made Us All More Human

    OK, We’ve Just Realized That WFH Has Made Us All More Human

    The Most Promising COVID-19 Vaccines in Development

    The Most Promising COVID-19 Vaccines in Development

    7 Key Life Science Marketing Trends

    7 Key Life Science Marketing Trends

    View all Updates